Financials
Financial year 2025
Gross margin
€ 7.4 million
▲ 73% vs 2024
Profit
Healthy€ 3 million
▼ 5% vs 2024
Debts
Normal€ 25.7 million
▲ 11% vs 2024
ORSA TECH from Marche-en-Famenne, company number BE0882104835, closed financial year 2025 with a result of € 3 million after tax. For that financial year ORSA TECH recorded a gross margin of € 7.4 million and equity of € 12.9 million. Compared with financial year 2024, the result moved from € 3.1 million to € 3 million. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on October 29, 2025.
What happened at ORSA TECH?
What happened at ORSA TECH in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 3 million (▼ 5% vs 2024). Source: NBB ↗
- Andrea CIOBANU became a director. NBB
- Georges COTTIN became a director. NBB
- INVESTSUD SA became a director. NBB
- Nadia YAICHE-VERWILGHEN became a director. NBB
- Marc DECHAMPS became a director. NBB
- Benoit COPPEE became a director. NBB
- Marc BREUSKIN became a director. NBB
In short
From € 1.1 million loss in 2022 to € 3 million profit in 2025.
Paid € 2.9 million in corporate taxes since 2022.
Best year ever: 2024, with € 3.1 million profit.
Paid out € 1.1 million in dividends to the owners in total.
A new publication or filing at ORSA TECH? We notify you, reason included.
Follow ORSA TECHNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind ORSA TECH are Andrea CIOBANU, Benoit COPPEE, Marc DECHAMPS, Geoffroy JACOBS, Georges COTTIN and INVESTSUD SA. The shares are held by Wallonie Entreprendre (50%) and INVESTSUD SA (50%). It owns 21.1% of CURVO, 14.2% of OPAL SYSTEMS, 14.2% of ATB THERAPEUTICS, 14% of BIOXODES, 9.7% of AGRICELLS and 8.8% of DEUTERONCOLOGY itself.
Directors
According to the 2025 annual accounts
Andrea CIOBANU
Director
since 2023
since 2020
since 2021
Geoffroy JACOBS
Director
since 2017
Georges COTTIN
Director
since 2023
Director · represented by Pierre DETRIXHE
Also active at: LASERE, MARCHANDISE, INVESTSUD PARTICIPATIONS +1 more
since 2023
since 2023
Marc BREUSKIN
Director
since 2018
since 2017
Shareholders
Participations
21.1%
14.2%
14.2%
14%
9.7%
8.8%
7.1%
SAMABRIVA
6.2%
5.9%
5.1%
4.5%
ADIPOPHARMA
4.4%
3.9%
BRENUS PHARMA
3.9%
3.8%
2.9%
2.8%
2.6%
2.3%
2.1%
1.5%
1.1%
0.8%
0.5%
Establishments
Establishment units
Physical locations of this company
Marche,Rue de la Plaine 11
6900 Marche-en-Famenne
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 10 companies are registered at this address.
ORSA FUND same network
€ 2.6 million revenue · 2025
Agence Prévention et Sécurité
€ 619,670 gross margin · 2024
ORSA IMMO same network
€ -79,283 gross margin · 2025
FINANCIERE DU SUD - EST
€ 167,346 revenue · 2025
ORSA PARTS same network
€ -430 gross margin · 2025
+5 more
Details
- Company number
- 0882.104.835
- VAT number
- BE 0882.104.835
- Registered office
- Marche,Rue de la Plaine 11, 6900 Marche-en-Famenne
- Names & denominations
- ORSA TECH
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 14 June 2006
- Peppol
- Active · Active since 12 May 2025
- Activities · NACE
Activiteiten van bedrijfs- en werkgeversorganisaties